Related Experiment Video
Updated: May 5, 2026
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
GMP in donor centres
1Octapharma Plasma GmbH, Langenfeld, Germany.
Insights
Implementing Good Manufacturing Practice (GMP) ensures donor and blood product safety. This review details GMP principles for quality management in blood collection and apheresis procedures.
Area of Science:
- Blood banking and transfusion medicine
- Regulatory affairs in healthcare
- Quality management systems
Background:
- Blood component collection and processing must adhere to established guidelines for donor safety and product quality.
- Specific guidelines exist for blood collection, processing, and apheresis procedures.
- Adherence to Good Manufacturing Practice (GMP) is mandatory for blood donor centers.
Purpose of the Study:
- To review the principles of Good Manufacturing Practice (GMP).
- To assess the impact of GMP on quality management within blood donor centers.
- To provide practical guidance on managing GMP in blood collection and processing.
Main Methods:
- Review of European GMP guidelines relevant to medicinal product manufacturing.
- Analysis of GMP requirements for quality control, management, documentation, and manufacturing processes.
- Examination of risk management strategies for identifying and mitigating production failures.
Main Results:
- European GMP guidelines promote standardization in the production of medicinal products.
- GMP outlines essential requirements for quality control, management, documentation, and manufacturing.
- Risk management is a key component of GMP for identifying and quantifying production process failures.
Conclusions:
- Implementation of Good Manufacturing Practice (GMP) is crucial for ensuring both donor and product safety.
- GMP provides a framework for standardized and high-quality blood component production.
Background:
Collection and production of blood components should be in line with current blood guidelines to ensure both donor safety and the quality of the blood product. Guidelines were developed for the whole process of blood collection and processing as well as for apheresis procedures. Implementation of such Good Manufacturing Practice (GMP) is mandatory for donor centres.
Design:
Principles of GMP and its impact on quality management for the donor centre are reviewed in the present paper. Relevant GMP chapters and practical issues show how to manage GMP.
Results:
The European GMP guideline helps to standardize the production of medicinal products. Requirements for quality control and management, documentation and manufacturing are described in GMP guidelines. Risk management helps to identify and quantify failures in the production process.
Conclusion:
Implementation of GMP ensures donor and product safety.
